U.S. stocks tumbled Friday after President Trump posted on Truth Social that he may cancel a planned meeting with China's president and that he is considering "a massive increase in tariffs" on ...

What if the storage system you rely on suddenly gave you the freedom to choose? For years, Synology users have been locked into using proprietary drives, a policy that frustrated many who sought ...

To say that it’s a bit clustered would be like saying SEC fans care about football. In the ever-scrutinized, but still somewhat relevant Associated Press Top 25, you can find half the SEC ranked ...

When it comes to heavy-duty diesels, enthusiasts and truck owners inevitably circle back to the best American diesel engines: Ford's 7.3L PowerStroke, Dodge's 5.9L Cummins, and GM's 6.6L Duramax. If ...

Chemistry Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), P.O. Box 90905, Riyadh 11623, Saudi Arabia ...

Pfizer will acquire Metsera in a deal worth $4.9 billion up front and up to $7.3 billion if the acquired assets succeed further. Metsera is developing anti-obesity treatments that could differentiate ...

Metsera brings its portfolio of experimental obesity drugs, with MET-097i, a GLP-1 injectable, and MET-233i, which mimics the pancreatic hormone amylin, being the key among them. MET-233i is being ...

Fans of reMarkable’s series of notepad-like note-taking E-Ink tablets have something new to get excited about today: a new version of the devices called the reMarkable Paper Pro Move, which takes the ...

Cloudflare on Tuesday said it automatically mitigated a record-setting volumetric distributed denial-of-service (DDoS) attack that peaked at 11.5 terabits per second (Tbps). "Over the past few weeks, ...

According to IDC, India’s smartphone market shipped 70 million units in H1 2025, growing 0.9 percent YoY. In Q2 alone, shipments rose 7.3 percent YoY to 37 million. The growth was driven by new model ...

Pfizer is doing well enough to pay down debt while sustaining its generous dividend. Oncology and specialty drugs are driving growth. The stock has a high ceiling heading into next year. But Pfizer's ...